Pacák K, Nedvídková J
Clinical Neuroscience Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Healths, Bethesda, Maryland, USA.
Cas Lek Cesk. 1995 May 17;134(10):296-301.
Estrogens and thyroid hormones contribute importantly to cell proliferation and tumor transformation in the pituitary gland. The purpose of the present article is provide review about neurotransmitters, chemicals, and receptors that are involved in estrogen-induced anterior pituitary growth. Central dopaminergic and noradrenergic systems are thought to be the most important systems in regulation of pituitary growth and function. For this purpose authors discuss some of their past and present data suggesting that estrogen-induced anterior pituitary pituitary growth is associated with decreased synthesis and metabolism of central catecholamines and increased adenohypophyseal dopamine 2 receptors. Treatment with thyroid hormones prevents both estrogen-induced catecholaminergic inhibition and dopamine D2 receptor increment in the anterior pituitary gland. Further studies focusing on central catecholaminergic systems, pituitary receptor equipment and mechanisms of intracellular signal transduction will be of value to better understand pituitary tumor formation and possibly to find new approaches toward treating patients with these tumors.
雌激素和甲状腺激素对垂体中的细胞增殖和肿瘤转化起着重要作用。本文旨在综述与雌激素诱导的垂体前叶生长相关的神经递质、化学物质和受体。中枢多巴胺能和去甲肾上腺素能系统被认为是调节垂体生长和功能的最重要系统。为此,作者讨论了他们过去和现在的一些数据,这些数据表明雌激素诱导的垂体前叶生长与中枢儿茶酚胺的合成和代谢减少以及腺垂体多巴胺2受体增加有关。甲状腺激素治疗可预防雌激素诱导的垂体前叶儿茶酚胺能抑制和多巴胺D2受体增加。进一步关注中枢儿茶酚胺能系统、垂体受体装备和细胞内信号转导机制的研究,对于更好地理解垂体肿瘤的形成以及可能找到治疗这些肿瘤患者的新方法具有重要价值。